Sentinel lymph node biopsy in patients with gynecologic cancers   Expert panel statement from the International Sentinel Node Society  Meeting,  February 21, 2008.
An expert panel was formed for the 6th biennial International Sentinel Node Society to review the status of sentinel lymph node biopsy (SLNB) in gynecologic oncology. This paper presents the opinion of the experts who participated regarding indications for SLNB, technical considerations, and directions for future investigation.
Levenback
Charles F
CF
Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. clevenba@mdanderson.org
van der Zee
Ate G J
AG
Rob
Lukas
L
Plante
Marie
M
Covens
Al
A
Schneider
Achim
A
Coleman
Robert
R
Solima
Eugenio
E
Hertel
Hermann
H
Barranger
Emmanuel
E
Obermair
Andreas
A
Roy
Michel
M
D005260:Female; D005833:Genital Neoplasms, Female / Q000473:pathology*; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D021701:Sentinel Lymph Node Biopsy / Q000379:methods* / Q000592:standards